C13Chref-Selected Reading, Borderland

Selected Reading, Borderland (I) (tier 2)

Clonality:

Dercure O,Kadin MF: T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol 2000;136:1483-6.

el-Azhary RA, et al: Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. J Am Acad Dermatol 1994;30: 210-8.

Hammer E, et al: Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol 1993;28: 426-33.

Magro C, et al: Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002;33: 788-95.

Morice WG, Kurtin PJ, Myers JG:: Expression of cytolytic lymphocyte-associated antigens in pulmonary lymphomatoid granulomatosis. Am J Clin Pathol 2002;118:391-8.

Pinkus GS, et al: Langerhans cell histiocytosis: immunohistochemical expression of Fascin, a dendritic cell marker. Am J Clin Pathol 2002;118: 335-43.

Scarisbrick JJ, et al: Pseudocarcinomatous change in lymphomatoid papulosis and primary  cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients. J Am Acad Dermatol 2001;44:239-47.

Tappero JW, et al: Kaposi’s sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria, and therapy. J Am Acad Dermatol 1993;28:371-95.

Vonderheid EC, Sajjadian A, Kadin ME: Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD3-positive lymphoproliferative disorders. J Am Acad Dermatol 1996;34: 470-81.

Wechsler J, et al: Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. M Am Acad Dermatol 1998;134: 479-84.

Genodermatoses:

Burgdorf WHC, Dintiman BJ: Genodermatoses. J Am Acad Dermatol 1991;5: 840-4.

Moh’s (micrographic) surgery:

McGovern TW, Leffell DJ: Moh’s surgery: the informed view. Arch Dermatol 1999;135: 1255-9.

Rosai J: Moh’s micrographic surgery: a pathologist’s view. Arch Dermatol 1999;135: 1171-73.

Lymphoproliferative disorders:

Dawe RS, Crombie IK: The natural history of chronic actinic dermatitis. Arch Dermatol 2000;136: 1215-20.

Toonstra J, et al: Actinic Reticuloid. J Am Acad Dermatol 1989;21: 205-14.

 

Philosophy (financial concerns vs common sense)

Penneys NS: Histopathologist: to step section or not? Arch Dermatol 2001;137;375-6.

Shea Cr,Carag Hr,Prieto VG: In reply. Arch Dermatol 2001;137: 276-7.

Philosophy (forensics presented as science):

Ackerman AB: Response. J Am Acad Dermatol 2001;45: 467-9.

Flaxman BA: Actinic keratoses - malignant or not? J Am Acad Dermatol 2001;45: 466-7.

 

Ackerman AB: In reply. Arch Dermatol 2000; 136: 1271.

Gniadecki R: Rigid definitions restrict the evolution of understanding. Arch Dermatol 2000;136: 1271.

 

Philosophy (one man’s view, but often encountered)

Ackerman AB: Dermatology awake - dermatopathology is in peril. J Am Acad Dermatol 1991;25: 128-30.

 

Philosophy (what’s in a name?)

Brody HJ, Coleman WP: What’s in a name? Arch Dermatol 2000;136;1406-7.

Philosphy (cosmetic surgery)

Ringel EW: The morality of cosmetic surgery for the aging. Arch Dermatol 1998;134: 427-31.

Radiation therapy:

Goldschmidt H, Breneman JC, Breneman DL: Ionizing radiation therapy in dermatology. J Am Acad Dermatol 1994;30: 157-82.

Xeroderma pigmentosum:

Gilchrest BA, et al: The human sunburn reaction: Histologic and biochemical studies. J Am Acad Dermatol 1981;5: 411-422.

Stern JB, et al: Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion. J Am Acad Dermatol 1993;28:591-4.

 

GREEN BARS provide access to WEB SITES

MAUVE BARS provide access to each of the SECTIONS on this SITE

BEIGE BARS provide access to CHAPTERS oF this SECTION as a continuation of the cluster of vertically oriented BROWN BARS above

next PAGE along same tier in spatial sequence

BACK TO PREVIOUS PAGE along tier in spatial sequence

UP ONE PAGE (to next tier); if at tier 3 up to respective parent PAGE; if at tier 2, then up to HOME

BuiltWithNOF